Share Name Share Symbol Market Type Share ISIN Share Description
Seneca Growth Capital Vct Plc LSE:HYG London Ordinary Share GB0031256109 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 32.50 0.00 01:00:00
Bid Price Offer Price High Price Low Price Open Price
27.00 38.00 32.50 32.50 32.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments -0.16 3
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 32.50 GBX

Seneca Growth Capital Vct (HYG) Latest News

Real-Time news about Seneca Growth Capital Vct Plc (London Stock Exchange): 0 recent articles
More Seneca Growth Capital Vct News
Seneca Growth Capital Vct Investors    Seneca Growth Capital Vct Takeover Rumours

Seneca Growth Capital Vct (HYG) Discussions and Chat

Seneca Growth Capital Vct Forums and Chat

Date Time Title Posts
22/9/202114:39HYGEA VCT : medical technology company VCT278
17/1/200519:21Honeygrove Group - was Propan Homes514
16/10/200316:41HYG Charts2

Add a New Thread

Seneca Growth Capital Vct (HYG) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Seneca Growth Capital Vct trades in real-time

Seneca Growth Capital Vct (HYG) Top Chat Posts

Seneca Growth Capital Vct Daily Update: Seneca Growth Capital Vct Plc is listed in the Equity Investment Instruments sector of the London Stock Exchange with ticker HYG. The last closing price for Seneca Growth Capital Vct was 32.50p.
Seneca Growth Capital Vct Plc has a 4 week average price of 32.50p and a 12 week average price of 31p.
The 1 year high share price is 41.80p while the 1 year low share price is currently 22p.
There are currently 8,115,376 shares in issue and the average daily traded volume is 4,929 shares. The market capitalisation of Seneca Growth Capital Vct Plc is £2,637,497.20.
timbo003: I have now settled up on my Mello Charity wager on Arecor made last June at the time of the IPO: https://melloevents.com/charity-pledge/ Target price 325p by Dec 31st 2021 https://tinyurl.com/mykd6d5a Looking at the table of selections, only 15 out of 119 have managed to hit or exceed target so far, hopefully some of the others will catch up as it is a commendable idea.
rivaldo: AREC is zooming up again - now at 380p. HYG held 223,977 shares at 30th June, so that's worth £0.85m now, alongside the 11m SCLP shares at 21.75p now worth £2.63m.
jonesy100: AREC up 30% on insulin candidate news.Could start to really move HYG NAV if this gathers momentum. Reckon we are now at 41p
drdre: Hi All, Have been looking into HYG and it looks intriguing - I was attracted by the yield and the cumulative 65p or so which has been returned. I note that they are effectively not going to look for new opps via the ords. Is HYG future performance therefore linked to performance of Arecor and Scancell moving forward? I did read the AR and I can't see much to come from the unquoted investments - it seems only Fuel3D and Insense have any potential? Coming from the point of view of a potential investor, I worry that the boat may have sailed here but would welcome more educated views. Mine are based on poring through the last AR. The dividends returned to date have been exceptional and my feeling is that there could be up to 50% to gain here (looking at the NAV) but it is now, in effect, a closed shop? Happy to be corrected.
rivaldo: Nice IPO debut for AREC. At the current 247p that would value HYG's stake at almost £0.5m. HYG have 12m SCLP shares, which at the current 19p are worth £2.28m. There's also around £1.5m cash, plus holdings in Fuel 3D and Insese worth £320k. That's around £4.6m of NAV, i.e 57p per share. The share price is now at quite a discount assuming my calculations are correct (my only query is did the 5/10/20 £400,000 5p dividend come out of that cash pile?).
rivaldo: Timbo et al, have you or can you work out roughly what HYG's shareholding is now in Arecor at the new £62.5m m/cap? There are 27,683,532 shares now in issue, and there were 18.83m in issue pre-placing. Did HYG have 1.1% of that 18.83m shares? At 226p your prior calculation indicates a valuation of around £0.44m to HYG, which would be about right on that basis.
timbo003: >>>>SPB 👍👍👍 >>>All I have now read and reread the relevant parts of the invetor roadshow slides and the draft AIM prospectus and I think I have now (at last) got my head around the likely valuation of the HYG stakes in Arecor following the IPO price (and also the value of the Oxford Tech VCT stakes in Arecor) Based on the info available * £4.4m CLN conversion at a 10% discount * £20m new money * 250p/share IPO * £70m post IPO valuation at 250p/share I come up with the following valuations for each of the four VCTs The Hygea and Ox Tech VCT numbers do not correspond exactly and I'm not sure why that is, perhaps it is the different reporting dates and methods for HYG vs OX VCTs? but I am reasonably confident that the post IPO values in the table will be fairly close to reality.
timbo003: I have now been offered the opportunity to take one of the charity pledge slots at tomorrow night's Mello Healthcare Webinar, so I thought I would go for Arecor as it will be new to most investors (so hopefully of interest) . I will mention (if I remember) that investors can take a position in Arecor before the IPO by investing in one of the Oxford Tech VCTs or Hygea VCT My charitable pledge is for £200 if Arecor increase to 325p/share by December 31st 2021 (a 30% increase from the IPO price). I feel reasonably confident that I will need to get the cheque book out to fulfil the pledge I am sandwiched between the presentations by Angle and Polarien, I hold both of those two, so I am looking forward to it. The agenda is below for anyone interested, there is a 70% off discount code ( TGDisc ) for anyone who wishes to attend https://melloevents.com/investingoodhealth/
rivaldo: I note that the various Oxford Technology VCTs have issued RNS's about the Arecor IPO. For example, here's OXF's - their share price has increased by 50% this morning! Why haven't HYG done the same - the increase in valuation is obviously material to the £2.6m m/cap. They just need to lift the wording from OX4's RNS.... Https://www.investegate.co.uk/oxford-tech-4-vct--oxf-/gnw/portfolio-update/20210518070000H5462/
rivaldo: Congrats notsostupidboypike :o)) You must be in for some serious gains I'd have thought. Confirmation here that Arecor's IPO is expected in "early June": Https://www.investegate.co.uk/aim/rns/schedule-one---arecor-therapeutics-plc/202105170700156941Y/ Jonesy100, I was using HYG's last reported NAV of 37.6p NAV at 5th Oct'20, when SCLP were 16.5p. Also, HYG had 1.3% ownership of Arecor at July'20's results. Perhaps you have more up to date info.
Seneca Growth Capital Vct share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Seneca Gro..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210924 19:48:09